Skip to main content




-- West Pharmaceutical Services



) has been downgraded by TheStreet Ratings from buy to hold. The company's strengths can be seen in multiple areas, such as its expanding profit margins and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow.

West Pharmaceutical Services, Inc. manufactures and sells components and systems for injectable drug delivery and plastic packaging, and delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company has a P/E ratio of 17.8, below the average health services industry P/E ratio of 18.1 and below the S&P 500 P/E ratio of 23.4. West Pharmaceutical Services has a market cap of $1.4 billion and is part of the

health care

TheStreet Recommends

sector and

health services

industry. Shares are up 0.7% year to date as of the close of trading on Thursday.

You can view the full

West Pharmaceutical Services Ratings Report

or get investment ideas from our

investment research center